Sector revisions Amarin Corporation plc

Stocks

Market Closed - Nasdaq 16:00:00 2026-09-04 EDT			5-day change	1st Jan Change
13.63 ^USD	-0.58%		-2.43%	-2.33%

09-01	European Equities Traded in the US as American Depositary Receipts Edge Higher in Tuesday Trading	MT
08-31	Amarin Highlights New Reduce-It and Mechanistic Data At European Society of Cardiology Congress	CI

Sector:

Location:

X axis:

Main competitors

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	1m. Revenue rev.	4m. EPS revision	4m. Revenue rev.	1y. EPS revision	1y. Revenue rev.	Visibility	Nbr of analysts
	AMARIN CORPORATION PLC							2
	WUXI APPTEC CO., LTD.							18
	ARGENX SE							15
	INSMED INCORPORATED							22
	BIONTECH SE							20
	WUXI BIOLOGICS (CAYMAN) INC.							24
	GENMAB A/S							15
	PHARMAESSENTIA CORPORATION							8
	SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD.							18
	EXELIXIS, INC.							16
	SUMMIT THERAPEUTICS INC.							13
	MADRIGAL PHARMACEUTICALS, INC.							16
	ARROWHEAD PHARMACEUTICALS, INC.							11
	AKESO, INC.							21
	CYTOKINETICS, INCORPORATED							20
	VAXCYTE, INC.							9
	REMEGEN CO., LTD.							16
	IMMUNITYBIO, INC.							4
	BELITE BIO, INC							9
	Average							15
	Weighted average by Cap.							17